Get the Stockscreener App
14.16
2.48%
-0.36
After Hours:
14.16
Eton Pharmaceuticals Inc stock is traded at $14.16, with a volume of 216.80K.
It is down -2.48% in the last 24 hours and down -0.63% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$14.52
Open:
$14.55
24h Volume:
216.80K
Relative Volume:
0.47
Market Cap:
$379.74M
Revenue:
$31.38M
Net Income/Loss:
$-6.69M
P/E Ratio:
-54.46
EPS:
-0.26
Net Cash Flow:
$-1.84M
1W Performance:
-7.87%
1M Performance:
-0.63%
6M Performance:
-19.91%
1Y Performance:
+293.33%
1-Day Range:
$14.04
$14.79
1-Week Range:
$14.04
$15.48
52-Week Range:
$3.2519
$21.48
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
14.16 | 389.39M | 31.38M | -6.69M | -1.84M | -0.26 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Published on: 2025-07-30 01:43:42 - metal.it
Short Term Charts Align With Long Term Uptrend in Eton Pharmaceuticals Inc.Conservative Long Term Growth Plans Under Review - metal.it
RSI and MACD Indicate Shift in Eton Pharmaceuticals Inc. SentimentHigh Growth Low Risk Stock Selection Gets Analyst Nod - metal.it
How to interpret RSI for Eton Pharmaceuticals Inc. stockFree Step-by-Step Trade Signal Implementation - Newser
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - GlobeNewswire
What catalysts could drive Eton Pharmaceuticals Inc. stock higher in 2025Outperformance with explosive growth - jammulinksnews.com
Why is Eton Pharmaceuticals Inc. stock attracting strong analyst attentionCapital growth strategies that work - jammulinksnews.com
How Eton Pharmaceuticals Inc. stock reacts to Fed policy changesAlpha Stock Picks with Chart Confirmation - Newser
How volatile is Eton Pharmaceuticals Inc. stock compared to the marketCapitalize on fast-growing stocks today - jammulinksnews.com
How does Eton Pharmaceuticals Inc. compare to its industry peersMaximize gains with proven stock analysis - jammulinksnews.com
What are the technical indicators suggesting about Eton Pharmaceuticals Inc.Achieve impressive returns with smart timing - jammulinksnews.com
Is it the right time to buy Eton Pharmaceuticals Inc. stockCapitalize on market momentum for profits - jammulinksnews.com
What is the dividend policy of Eton Pharmaceuticals Inc. stockFree Market Volatility Navigation Tips - jammulinksnews.com
What is the risk reward ratio of investing in Eton Pharmaceuticals Inc. stockDiscover breakthrough trading strategies - jammulinksnews.com
Eton Pharmaceuticals Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingLow Volatility High Yield Stocks - Newser
What drives Eton Pharmaceuticals Inc. stock priceAccelerated financial growth - Autocar Professional
How high can Eton Pharmaceuticals Inc. stock price go in 2025Strongest growth potential - jammulinksnews.com
Eton Pharmaceuticals Inc. Stock Analysis and ForecastConsistent triple-digit returns - jammulinksnews.com
What analysts say about Eton Pharmaceuticals Inc. stockLightning-fast capital gains - jammulinksnews.com
Is Eton Pharmaceuticals Inc. a good long term investmentRapid return acceleration - jammulinksnews.com
What makes Eton Pharmaceuticals Inc. stock price move sharplyHigh Yield Opportunities - Newser
Top Growth Companies With Insider Stakes July 2025 - simplywall.st
B. Riley Analysts Lift Earnings Estimates for ETON - Defense World
B. Riley Boosts Earnings Estimates for Eton Pharmaceuticals - Defense World
ETON’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com
How Eton Pharmaceuticals Inc. stock performs during market volatilityLow Risk Profit Ideas - Newser
Why Eton Pharmaceuticals Inc. stock attracts strong analyst attentionCapital Preservation Investment Ideas - Newser
Eton Pharmaceuticals: A Contrarian Play on Delayed Catalysts and Long-Term Value - AInvest
Eton Pharma Near Term Catalysts Vanish (NASDAQ:ETON) - Seeking Alpha
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):